Effect of chlorogenic and gallic acids combined with azoles on antifungal susceptibility and virulence of multidrug-resistant Candida spp. and Malassezia furfur isolates.


Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
10 Nov 2020
Historique:
received: 12 01 2020
accepted: 25 02 2020
revised: 19 02 2020
pubmed: 3 4 2020
medline: 26 5 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

Chlorogenic acid (CHA) and gallic acid (GA) are safe natural phenolic compounds that are used as enhancers of some drugs in influencing antioxidant, anticancer, and antibacterial activities. Among fungi, Candida spp. and Malassezia spp. are characterized by an increasing prevalence of multidrug resistance phenomena and by a high morbidity and mortality of their infections. No data are available about the efficacy of CHA and GA combined with azoles on the antifungal susceptibility and on the virulence of both fungi. Therefore, their antifungal and antivirulence effects have been tested in combination with fluconazole (FLZ) or ketoconazole (KTZ) on 23 Candida spp. and 8 M. furfur isolates. Broth microdilution chequerboard, time-kill studies, and extracellular enzymes (phospholipase and hemolytic) activities were evaluated, displaying a synergistic antifungal action between CHA or GA and FLZ or KTZ on C. albicans, C. bovina, and C. parapsilosis, and antagonistic antifungal effects on M. furfur and Pichia kudriavzevii (Candida krusei) isolates. The time-kill studies confirmed the chequerboard findings, showing fungicidal inhibitory effect only when the GA was combined with azoles on Candida strains. However, the combination of phenolics with azoles had no effect on the virulence of the tested isolates. Our study indicates that the combination between natural products and conventional drugs could be an efficient strategy for combating azole resistance and for controlling fungistatic effects of azole drugs.

Identifiants

pubmed: 32236482
pii: 5814639
doi: 10.1093/mmy/myaa010
doi:

Substances chimiques

Antifungal Agents 0
Azoles 0
Chlorogenic Acid 318ADP12RI
Gallic Acid 632XD903SP
Phospholipases EC 3.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1091-1101

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Wafa Rhimi (W)

Dipartimento di Medicina Veterinaria, Università degli Studi di Bari, Aldo Moro, Bari, Italy.

Chioma Inyang Aneke (CI)

Dipartimento di Medicina Veterinaria, Università degli Studi di Bari, Aldo Moro, Bari, Italy.
Department of Veterinary Pathology and Microbiology, University of Nigeria, Nsukka, Nigeria.

Giada Annoscia (G)

Dipartimento di Medicina Veterinaria, Università degli Studi di Bari, Aldo Moro, Bari, Italy.

Domenico Otranto (D)

Dipartimento di Medicina Veterinaria, Università degli Studi di Bari, Aldo Moro, Bari, Italy.

Teun Boekhout (T)

Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
The Institute for Biodiversity and Ecosystem Dynamics (IBED), University of Amsterdam, Amsterdam, The Netherlands.
Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Military Medical University, Shanghai, China.

Claudia Cafarchia (C)

Dipartimento di Medicina Veterinaria, Università degli Studi di Bari, Aldo Moro, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH